ERBB2 and breast neoplasm: The clinical data show that a link exists between hMena and HER2 overexpression, confirming our previous results [15], [16] and further evidences that, according to the molecular classification of breast tumors [21], hMena overexpression is more frequent in the HER2 subtype.